Israel Cañadas, Ph.D.
Israel received his B.A. in Biology at University of Barcelona. He completed his Ph.D. at Pompeu Fabra University and Hospital del Mar d'investigacions Mèdiques Institute, focusing on the study of lung cancer biology and the identification of novel therapeutic targets and biomarkers. Then, he joined the Barbie Lab at Dana-Farber Cancer Institute where he characterized mechanisms of innate immunity in lung cancer to better understand immunotherapy. Afterwards, Israel moved to Fox Chase Cancer Center to establish his independent lab that combines his interests in cancer biology and immunology. Beyond science, Israel enjoys traveling around the world, watching TV shows, reading and spending time with friends and family.
Xueying Ma, MS, MB
Sr. Scientific Associate
Xueying received both her B.S and M.S in biology at Lanzhou University. She joined Xiyuan Hospital of the China Academy of Chinese Medical Science, with a focus on preclinical studies of Chinese herbal medicines. She then moved to Fox Chase Cancer Center to work in virology and immunology, during which she received a MB (ASCP) certification in addition to work as Clinical Flow Cytometry Technologist for 3 years. She has deep laboratory experience, including molecular biology, animal models, tissue culture, flow cytometry, etc. Xueying enjoys both independent and collaborative work. Outside of work, she enjoys traveling, reading and spending time with her family.
Takahiko Murayama, Ph.D.
Takahiko received his B.A. in Pharmaceutical Science at Chiba University. He completed his Ph.D. at the University of Tokyo, focusing on the study of oncogenic mechanisms of newly identified fusion gene in lung cancer, as well as the characterization of cancer stem-like cell properties in breast cancer. Due to moving of his previous laboratory, he continued his research at Kanazawa University. Then, he joined Dr. Cañadas laboratory at Fox Chase Cancer Center. On his day off, Takahiko enjoys reading, exercising and traveling.
Rahul M. Prasad, MD.
Rahul earned a B.S. in Biology in 2013 at the University of Toledo (Ohio, USA), then stayed and completed his M.D. in 2017. During that time he worked in a variety of basic science and clinical research groups. After one year of residency, he moved to Fox Chase Cancer Center to start a postdoc in Drs. Bellacosa and Yen's Labs. Rahul explored how TDG, an enzyme involved with DNA demethylation, can be used as an anti-cancer target and also the epigenetic regulation of the human centromere. After two years, Rahul joined Dr. Canadas' lab to study the connections between dsRNA from endogenous retroviruses and cancer susceptibility to immunotherapy. Rahul enjoys music, satirical Netflix shows, baked goods (eating and making), and most ramen noodle restaurants.
Temple University PhD student
Xinpei received his B.A. at the University of Pennsylvania with a concentration in Molecular Biology. He gained experience in fields of hepatology, virology and neuroscience after graduation. After years of exploration, he discovered his passion for research, then he started his Ph.D. at the Lewis Katz School of Medicine at Temple University. While rotating at Dr. Cañadas lab, cancer heterogeneity amazed him. Xinpei now is part of the team in studying how to prime innate immunity to combat cancer. Science aside, Xinpei enjoys eating, hiking, listening to music, watching Sci-Fi shows and spending time with friends and family.